Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health care and social assistance tags : Biotech-beach save search
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
Published: 2023-11-30 (Crawled : 00:00) - biospace.com/
BIOR | $0.6 -6.56% -7.02% 520K
|
Health Care and Social Assistan...
|
| O: 3.31%
H: 2.4%
C: -0.8%
bt-600 fda treatment clearance application therapeutics
Biora Therapeutics Announces New Patents Covering its BioJet™ Systemic Oral Delivery PlatformIntellectual property relates to key features of the company’s liquid jet injection technology
Published: 2023-08-03 (Crawled : 18:00) - biospace.com/
BIOR | $0.6 -6.56% -7.02% 520K
|
Health Care and Social Assistan...
|
| O: -0.52%
H: 1.83%
C: 0.52%
technology therapeutics injection
Biora Therapeutics Announces Clinical Device Performance Study Results for its NaviCap™ Targeted Oral Delivery Platform Phase 1
Published: 2023-07-27 (Crawled : 13:00) - biospace.com/
BIOR | $0.6 -6.56% -7.02% 520K
|
Health Care and Social Assistan...
|
| O: -0.82%
H: 3.86%
C: 1.38%
device therapeutics results study platform
Biora Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
Published: 2023-03-23 (Crawled : 14:20) - biospace.com/
BIOR | $0.6 -6.56% -7.02% 520K
|
Health Care and Social Assistan...
|
| O: 0.36%
H: 8.7%
C: 4.35%
report year update therapeutics financial results
BioCorRx to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-06 (Crawled : 13:00) - biospace.com/
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
| Email alert
Add to watchlist
global conference
BioCorRx to Participate in the Benzinga All Access Event on July 15th
Published: 2022-07-13 (Crawled : 13:00) - biospace.com/
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
| Email alert
Add to watchlist
BioCorRx Announces First Subject Dosed in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Published: 2022-06-30 (Crawled : 17:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: 1.06%
H: 0.0%
C: 0.0%
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
|
| O: 6.44%
H: 0.81%
C: 0.81%
bicx104 treatment opioid trial
BioCorRx to Present at the LD Micro Invitational XII on June 7th
Published: 2022-05-31 (Crawled : 22:00) - biospace.com/
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
|
| O: -4.2%
H: 4.38%
C: 4.38%
BioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Published: 2022-04-27 (Crawled : 13:20) - biospace.com/
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
bicx104 treatment opioid trial
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.